Please login to the form below

Not currently logged in
Email:
Password:

GPI appoints commercial director

Alan Stewart joins the life science management consultancy's executive team

GPI Alan StewartLondon, UK-based Global Pricing Innovations has strengthened its executive team with the appointment of Alan Stewart as commercial director.

Stewart joins the pharmaceutical and biotech pricing solutions firm from IMS Health, where he served as a global pricing solution specialist.

Prior to this, he was a senior business account manager at Aachen, Germany-headquartered Grünenthal, and held a series of sales, brand marketing and strategy positions at Eli Lilly and Bayer.

Preeti Patel, chief executive of GPI, said: “I am thrilled that Alan is joining our team. We view his appointment as a sign of our commitment to being a leading provider in the industry.

“Alan is a true sales professional and shares our values, focus on innovation, and places the same strong emphasis on the customer experience as we do.

“Alan's wealth of experience within the industry and impeccable reputation for providing high quality service makes him the perfect addition for the company.”

16th January 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...